Business
CardioComm Solutions to Bring ECG Monitoring to Remote Patient and COVID-19 Monitoring Platforms
GEMS™ Mobile and the HeartCheck™ CardiBeat Integrated with the LiveCare Link+ ...
About this update from Cardiocomm Solutions, Inc.
[{"type":"text","content":"CardioComm Solutions to Bring ECG Monitoring to Remote Patient and COVID-19 Monitoring PlatformsGEMS™ Mobile and the HeartCheck™ CardiBeat Integrated with the LiveCare Link+ PlatformTORONTO, ON / ACCESSWIRE / December 15, 2020 / CardioComm Solutions, Inc. (TSXV:EKG) (\"CardioComm\" or the \"Company\"), a global provider of consumer heart monitoring and electrocardiogram (\"ECG\") device and software solutions, is pleased to confirm it has entered into a technology integration agreement with LiveCare Corp. (\"LiveCare\") and a Value-Added Reseller and Distribution Agreement with Alliance Tele-Med (\"Alliance\"), to provide integrated ECG monitoring through the LiveCare Link+ device and telemedicine platform.CardioComm confirms integration of their FDA and Health Canada cleared GEMS™ ECG management software, the wireless HeartCheck™ CardiBeat ECG monitor and access to the SMART Monitoring ECG reading service into the Link+ platform has been completed. Under the agreement, the GEMS™ Mobile app technology was embedded into the Link+ gateway device allowing ECGs to be transferred through the Link+ platform to the CardioComm SMART Monitoring ECG reading service. Once an ECG report is completed, the report findings are then securely transmitted to the Link+ platform and from there to the Link+ platform's remote patient monitoring teams.Link+ is a patented smart home gateway that integrates multiple key medical bio-sign monitoring devices in a patient's home through a proprietary, touch-free device which is always connected to the 4G network. There is no need for patients to connect to any specific Wi-Fi network for the Link+ to fully operate and, once activated, the Link+ transmits data directly to LiveCare's HIPAA compliant cloud. The Link+ is fully reimbursable through Medicare, Medicaid and many commercial insurance plans using multiple CPT codes.Through the addition of the GEMS™ technology into the Link+ gateway device, the Link+ device will be capable of recognizing multiple ECG devices with up to 12 leads of ECG recording and provide Link+ customers with more options in choosing a device of their preference. The HeartCheck™ CardiBeat will be the recommended device for remote ECG patient monitoring given its availability in Canada, the US and Europe. All recorded ECGs will be passed...